Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 147 No. 2526 (2017)

Lessons from the discontinuation of extracorporeal photopheresis

  • Kyle R. Brownback
DOI
https://doi.org/10.4414/smw.2017.14448
Cite this as:
Swiss Med Wkly. 2017;147:w14448
Published
30.06.2017

References

  1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987;316(6):297–303. https://doi.org/10.1056/NEJM198702053160603
  2. Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation. 2007;84(1):31–9. https://doi.org/10.1097/01.tp.0000267785.52567.9c
  3. Zic JA. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome. Dermatol Clin. 2015;33(4):765–76. https://doi.org/10.1016/j.det.2015.05.011
  4. Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S, et al. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation. J Clin Apher. 2016;31(4):347–52. https://doi.org/10.1002/jca.21404
  5. Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, et al.; Systemic Sclerosis Study Group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol. 2006;54(5):793–9. https://doi.org/10.1016/j.jaad.2005.11.1091
  6. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant. 2010;29(4):424–31. https://doi.org/10.1016/j.healun.2009.08.029
  7. Del Fante C, Scudeller L, Oggionni T, Viarengo G, Cemmi F, Morosini M, et al. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis. Respiration. 2015;90(2):118–28. https://doi.org/10.1159/000431382
  8. Robinson C, Huber LC, Murer C, Schuurmans MM, Malcolm Kohler M, Hofbauer GF, et al. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults. Swiss Med Wkly. 2017;146:w14429.
  9. Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant. 2012;31(9):950–7. https://doi.org/10.1016/j.healun.2012.05.002